SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-058571
Filing Date
2013-11-04
Accepted
2013-11-04 17:01:56
Documents
10
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v357806_10q.htm 10-Q 1102799
2 EXHIBIT 31.1 v357806_ex31-1.htm EX-31.1 11431
3 EXHIBIT 31.2 v357806_ex31-2.htm EX-31.2 12547
4 EXHIBIT 32.1 v357806_ex32-1.htm EX-32.1 11783
  Complete submission text file 0001144204-13-058571.txt   5676960

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT acur-20130930.xml EX-101.INS 857631
6 XBRL TAXONOMY EXTENSION SCHEMA acur-20130930.xsd EX-101.SCH 49281
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acur-20130930_cal.xml EX-101.CAL 14725
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acur-20130930_def.xml EX-101.DEF 229625
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE acur-20130930_lab.xml EX-101.LAB 321036
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acur-20130930_pre.xml EX-101.PRE 267830
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10113 | Film No.: 131189839
SIC: 2834 Pharmaceutical Preparations